Browsing by Subject "Drug development -- Government policy -- United States"

Now showing items 1-2 of 2

    • Deterring Inefficient Pharmaceutical Litigation: An Economic Rationale for the FDA Regulatory Compliance Defense 
      Viscusi, W. Kip; Rowland, Steven R.; Dorfman, Howard L.; Walsh, Charles J. (Seton Hall Law Review, 1994)
      This Article examines the interaction between direct regulation of pharmaceuticals under the Federal Food Drug and Cosmetic Act (FDCA) and the indirect regulation of pharmaceuticals provided by common law tort incentives. ...
    • Expedited protocol development: Boon or Bane? 
      Menon, Gourija S (2006-04-17)
      Department: Management of Technology
      Industries plagued by lengthy development times have always resorted to ad hoc resource allocation and expediting in an effort to reduce the development times. Instead of decreasing the time to market, these well meaning ...